Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03039738 · ClinicalTrials.gov registry record · NA

Surveillance Monitoring as an Alternative to Telemetry

A NA study, sponsored by Medtronic - MITG.

Terminated
Registry status
NA
Development phase
206
Enrollment target

NCT03039738: Clinical Trial NA study, sponsored by Medtronic - MITG.

NCT03039738 is a NA study that was terminated before completion, run by Medtronic - MITG. The registered enrollment target is 206 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03039738, a NA study, was terminated before completion, sponsored by Medtronic - MITG.

TERMINATED
Registry status
NA
Development phase
206 participants
Enrollment target

Study Summary

The purpose of the study is to evaluate the impact of surveillance monitoring versus telemetry monitoring on clinical, healthcare economics, resource utilization, and qualitative outcomes.

Primary Outcome

LOS will be determined by comparing LOS Between the Surveillance Monitoring and Telemetry Monitoring Period Arms.

Interventions

  • DEVICE Vital Sync IM & VPMP (Surveillance Monitoring)
  • DEVICE Telemetry Monitoring

Trial Details

FieldValue
Enrollment Target 206 participants
Start Date 2017-04-03
Est. Completion 2018-01-04
Phase NA
Medtronic - MITG

119 total trials

Why NCT03039738 stopped before completion

NCT03039738 is an interventional study that assigns participants to a tested intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 2 interventions - of which Vital Sync IM & VPMP (Surveillance Monitoring) is the first listed.

NCT03039738 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03039738 about?

NCT03039738 is a clinical study titled "Surveillance Monitoring as an Alternative to Telemetry". The purpose of the study is to evaluate the impact of surveillance monitoring versus telemetry monitoring on clinical, healthcare economics, resource utilization, and qualitative outcomes.

What is the current status of trial NCT03039738?

This trial is currently terminated. It is a NA study. The enrollment target is 206 participants. The study started on 2017-04-03. Estimated completion is 2018-01-04.

What interventions are being tested in trial NCT03039738?

The interventions under investigation include: Vital Sync IM & VPMP (Surveillance Monitoring) (DEVICE), Telemetry Monitoring (DEVICE).

Who is sponsoring clinical trial NCT03039738?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03039738's enrollment target sits among peer trials

206 499th of 2000 higher than 1,502 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03373968 · 206 participants · Phase 2

    Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

  • NCT03550391 · 206 participants · Phase 3

    Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

  • NCT04757116 · 206 participants · NA

    Post-Market Study to Assess iTind Safety in Comparison to UroLift

  • NCT05675865 · 206 participants · NA

    Cryoablation for Monomorphic Ventricular Tachycardia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03039738, the US trial registry maintained by the National Library of Medicine. NCT03039738 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.